Financial Comparison

Cipla Limited vs Sun Pharmaceutical Industries Limited

Click a ticker to view the full analysis.

CIPLA.NS vs

In short

Sun Pharmaceutical Industries Limited is the more profitable of the two, keeping 19.7% of revenue as net profit against 14.0% for Cipla Limited. Cipla Limited trades at the higher trailing P/E (39.0× vs 38.8× for Sun Pharmaceutical Industries Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Cipla Limited and 0 for Sun Pharmaceutical Industries Limited.

Based on filings for periods ending 31 Mar 2026 (CIPLA.NS) and 31 Mar 2026 (SUNPHARMA.NS) · Updated

FisclearScore Comparison

CIPLA.NS51Fair
SUNPHARMA.NS68Strong
Quality+5
89
94
Efficiency+15
47
62
Value+36
26
62
Cashflow+31
25
56
Regime
55
55
Peers+12
58
70

FisclearScore is a quantitative model. CIPLA.NS shown solid · SUNPHARMA.NS shown dashed. Not financial advice.

MetricCIPLA.NSSUNPHARMA.NS
Price₹1,397.10₹1,773.40
Market Cap₹1.13T₹4.25T
P/E (TTM)39.0x38.8x
P/B3.2x4.8x
Beta0.100.13
Div Yield0.93%0.90%
Revenue (TTM)₹277.1B₹582.2B
Net Income₹38.8B₹114.8B
Gross Margin62.3%77.4%
Risk Flags——

Related comparisons

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.